Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC
· Real-Time Price · USD
12.93
0.27 (2.13%)
At close: Aug 15, 2025, 3:59 PM
11.05
-14.54%
After-hours: Aug 15, 2025, 07:55 PM EDT
Benitec Biopharma Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | n/a | 6K | 6K | 6K | 13K | 61K | 75K | 547K | 540K | 534K | 545K | 73K | 75K | 28K | 4K | 59K | 17K | 44K | 120K |
Cost of Revenue | 91K | 181K | 182K | 76K | 69K | -21K | 19K | 227K | 152K | 152K | 111K | 111K | 103K | 110K | 134.64K | 166.64K | 213.64K | 253.64K | 665.11K |
Gross Profit | -91K | -175K | -176K | -70K | -56K | 82K | 56K | 320K | 388K | 382K | 434K | -38K | -28K | -82K | -130.64K | -107.64K | -196.64K | -209.64K | -545.11K |
Operating Income | -30.14M | -24.09M | -22.41M | -22.49M | -21.5M | -21.69M | -20.38M | -19.08M | -19.27M | -18.39M | -17.61M | -17.86M | -16.97M | -17.3M | -15.73M | -13.6M | -12.63M | -10.95M | -9.8M |
Interest Income | 823K | 823K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -26.49M | -21.41M | -20.86M | -21.75M | -21.69M | -21.81M | -20.42M | -19.56M | -19.97M | -18.85M | -18.26M | -18.21M | -17.14M | -17.78M | -16.21M | -13.88M | -12.81M | -11.01M | -9.85M |
Net Income | -26.49M | -21.41M | -20.86M | -21.75M | -21.69M | -21.81M | -20.22M | -19.88M | -20.28M | -18.98M | -18.58M | -18.02M | -16.96M | -17.78M | -16.21M | -13.88M | -12.81M | -11.01M | -9.85M |
Selling & General & Admin | 11.99M | 9.27M | 7.55M | 6.9M | 6.23M | 5.97M | 6.01M | 6.38M | 6.56M | 6.67M | 6.52M | 6.65M | 6.63M | 6.32M | 6.72M | 6.51M | 6.88M | 7.13M | 6.92M |
Research & Development | 18.15M | 14.73M | 14.77M | 15.61M | 15.28M | 15.88M | 14.54M | 12.77M | 12.76M | 11.77M | 11.15M | 11.27M | 10.42M | 11M | 9.03M | 7.02M | 5.61M | 3.65M | 3.08M |
Other Expenses | n/a | -16K | -32K | -50K | -130K | -114K | -48K | -30K | 50K | 21K | -29K | -29K | -29K | 7K | 17K | 17K | 12K | 5K | -5K |
Operating Expenses | 30.05M | 23.91M | 22.23M | 22.42M | 21.52M | 21.86M | 20.56M | 19.16M | 19.33M | 18.44M | 17.68M | 17.92M | 17.05M | 17.32M | 15.74M | 13.53M | 12.48M | 10.78M | 10M |
Interest Expense | 823K | 4K | 10K | 16K | 24K | 27K | 30K | 33K | 35K | 38K | 40K | 32K | 22K | 14K | 5K | 4K | 14K | 28K | 43K |
Selling & Marketing Expenses | 77K | -13K | -13K | -13K | -90K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.95M | 24.09M | 22.41M | 22.6M | 21.61M | 21.86M | 20.56M | 19.16M | 19.34M | 18.45M | 17.69M | 17.93M | 17.05M | 17.33M | 15.73M | 13.66M | 12.65M | 10.99M | 9.92M |
Income Tax Expense | n/a | n/a | -10K | -10K | -10K | -10K | -199K | 314K | 274K | 89K | 299K | -214K | -174K | 11K | 3K | 3K | 3K | -13K | -33K |
Shares Outstanding (Basic) | 38.6M | 22.08M | 10.64M | 10.09M | 10.44M | 10.3M | 8.63M | 6.58M | 1.65M | 6.48M | 2.55M | 1.92M | 1.92M | 1.92M | 1.92M | 1.66M | 1.12M | 1.01M | 260.79K |
Shares Outstanding (Diluted) | 38.6M | 22.08M | 10.64M | 10.09M | 10.47M | 10.31M | 8.63M | 6.58M | 1.65M | 6.49M | 2.55M | 1.92M | 1.92M | 1.92M | 1.92M | 1.66M | 1.12M | 1.01M | 260.79K |
EPS (Basic) | -1.63 | -2.21 | -3.2 | -4.1 | -4.94 | -6.78 | -7.07 | -10.09 | -13.94 | -14.48 | -17.89 | -18.75 | -18.3 | -22.08 | -23.5 | -39.09 | -56.97 | -66.66 | -77.25 |
EPS (Diluted) | -1.63 | -2.21 | -3.2 | -4.1 | -4.94 | -6.78 | -7.07 | -10.08 | -13.93 | -14.48 | -17.89 | -18.75 | -18.3 | -22.08 | -23.5 | -39.09 | -56.97 | -66.66 | -77.25 |
EBITDA | -29.94M | -23.94M | -22.12M | -22.29M | -21.33M | -21.44M | -20.09M | -19.21M | -19.64M | -18.5M | -17.84M | -17.81M | -16.61M | -17.25M | -15.72M | -13.38M | -12.38M | -10.6M | -9.47M |
EBIT | -19.14M | -23.42M | -21.6M | -22.49M | -21.67M | -21.78M | -20.39M | -19.53M | -19.93M | -18.81M | -18.23M | -18.19M | -16.98M | -17.63M | -16.06M | -13.7M | -12.73M | -10.94M | -9.8M |
Depreciation & Amortization | 263K | 353K | 352K | 343K | 336K | 339K | 300K | 320K | 299K | 320K | 392K | 392K | 431K | 432K | 434K | 424K | 408K | 388K | 324K |